Veterinary Medicines

Vetivex 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats

Authorised
  • Calcium chloride dihydrate
  • Potassium chloride
  • Sodium chloride
  • Sodium lactate
Download as PDF

Product identification

Medicine name:
Vetivex 11 (Hartmann's) solution for infusion for cattle, horses, dogs and cats
Infusolec Infusionsvätska, lösning
Active substance:
  • Calcium chloride dihydrate
  • Potassium chloride
  • Sodium chloride
  • Sodium lactate
Target species:
  • Cattle
  • Dog
  • Horse
  • Cat
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Calcium chloride dihydrate
    0.27
    milligram(s)
    /
    1.00
    millilitre(s)
  • Potassium chloride
    0.40
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium chloride
    6.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sodium lactate
    3.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        hour
    • Dog
    • Horse
      • Meat and offal
        0
        day
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QB05BB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industria Farmaceutica Galenica Senese S.r.l.
  • Infomed Fluids S.R.L.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 48074
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0512/001
Concerned member states:
  • Belgium
  • Denmark
  • France
  • Germany
  • Netherlands
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
Swedish (PDF)
Published on: 16/08/2023
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 15/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."